Glypican-3 expression and its relationship with recurrence of HCC after liver transplantation

doi:10.3748/wjg.v18.i19.2408

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 19

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3914)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-2) series.

Item

Count

PDF

393

HTML

3261

Figures (1-4)

138

Tables (1-2)

122

Sum=3914

May 21, 2012 (publication date) through May 18, 2024

Times Cited of This Article

Times Cited (42)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. May 21, 2012; 18(19): 2408-2414
Published online May 21, 2012. doi: 10.3748/wjg.v18.i19.2408

Full Size Figure Download Figure

Figure 4 Kaplan-Meier survival curves for recurrence-free survival after liver transplantation for hepatocellular carcinoma. A: with or without glypican-3 mRNA overexpression (> 3.5 × 10^-2) (P = 0.034, compared by log-rank test); B: with or without glypican-3 protein expression (P = 0.231, compared by log-rank test).

Citation: Wang YL, Zhu ZJ, Teng DH, Yao Z, Gao W, Shen ZY. Glypican-3 expression and its relationship with recurrence of HCC after liver transplantation. World J Gastroenterol 2012; 18(19): 2408-2414
URL: https://www.wjgnet.com/1007-9327/full/v18/i19/2408.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i19.2408